In one paragraphArticle in International journal of molecular sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
7 authors.
Arpita DaveUCLA Jules Stein Eye Institute and Department of Ophthalmology, David Geffen School of Medicine, University of California, Los Angeles, CA 90095, USA.ORCID 0009-0008-1873-0454 Anela TosevskaDepartment of Molecular, Cell, and Developmental Biology, University of California, Los Angeles, CA 90095, USA.
Marco MorselliDepartment of Molecular, Cell, and Developmental Biology, University of California, Los Angeles, CA 90095, USA.
Emily TomRobert M. Brunson Center for Translational Vision Research, Department of Physiology and Biophysics, Department of Ophthalmology and Visual Sciences, School of Medicine, University of California, Irvine, CA 92697, USA.
Matteo PellegriniDepartment of Molecular, Cell, and Developmental Biology, University of California, Los Angeles, CA 90095, USA.ORCID 0000-0001-9355-9564 Dorota Skowronska-KrawczykRobert M. Brunson Center for Translational Vision Research, Department of Physiology and Biophysics, Department of Ophthalmology and Visual Sciences, School of Medicine, University of California, Irvine, CA 92697, USA.ORCID 0000-0002-5758-4225 Roxana A RaduUCLA Jules Stein Eye Institute and Department of Ophthalmology, David Geffen School of Medicine, University of California, Los Angeles, CA 90095, USA.ORCID 0000-0002-5064-6403 Funding
NIH HHS 1R01EY000331-10NIH HHS 1R01EY025002-05Research to Prevent Blindness, Inc. na
6 · The paper itselfAbstract
Stargardt disease (STGD1), the most common inherited juvenile macular degeneration, is caused by biallelic mutations in the
Indexed as
ATP-Binding Cassette TransportersDNA MethylationMacular DegenerationRetinal Pigment EpitheliumStargardt DiseaseAnimalsDisease Models, AnimalEpigenesis, GeneticHumansMethyl-CpG-Binding Protein 2MiceMice, KnockoutAbca4 protein, mouseATP-Binding Cassette TransportersMethyl-CpG-Binding Protein 2DNA methylationmethyl-CpG-binding protein 2recessive Stargardt diseasereduced representation bisulfite sequencingretinal pigment epithelium
Identifiers
PMID41226778
PMCPMC12608875
What Socratic holds
Textmetadata
LicenceCC BY
Read underepoch 390